These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31678216)

  • 1. Further delineation of the phenotype of PAK3-associated x-linked intellectual disability: Identification of a novel missense mutation and review of literature.
    Nagy D; Farkas K; Armengol L; Segura M; Esi Zodanu GK; Csányi B; Zimmermann A; Vámos B; Széll M
    Eur J Med Genet; 2020 Apr; 63(4):103800. PubMed ID: 31678216
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel
    Iida A; Takano K; Takeshita E; Abe-Hatano C; Hirabayashi S; Inaba Y; Kosugi S; Kamatani Y; Momozawa Y; Kubo M; Nakagawa E; Inoue K; Goto YI
    Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31444167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A de novo mutation in the X-linked PAK3 gene is the underlying cause of intellectual disability and macrocephaly in monozygotic twins.
    Hertecant J; Komara M; Nagi A; Al-Zaabi O; Fathallah W; Cui H; Yang Y; Eng CM; Al Sorkhy M; Ghattas MA; Al-Gazali L; Ali BR
    Eur J Med Genet; 2017 Apr; 60(4):212-216. PubMed ID: 28126652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel PAK3 gene missense variant associated with two Chinese siblings with intellectual disability: a case report.
    Qian Y; Wu B; Lu Y; Zhou W; Wang S; Wang H
    BMC Med Genet; 2020 Feb; 21(1):31. PubMed ID: 32050918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing Reveals Novel Mutations in X-linked Intellectual Disability.
    Muthusamy B; Selvan LDN; Nguyen TT; Manoj J; Stawiski EW; Jaiswal BS; Wang W; Raja R; Ramprasad VL; Gupta R; Murugan S; Kadandale JS; Prasad TSK; Reddy K; Peterson A; Pandey A; Seshagiri S; Girimaji SC; Gowda H
    OMICS; 2017 May; 21(5):295-303. PubMed ID: 28481730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Molecular Aspects of the Neurodevelopmental Disorder Associated with PAK3 Perturbation.
    Pascolini G; Gaudioso F; Passarelli C; Novelli A; Di Giosaffatte N; Majore S; Grammatico P
    J Mol Neurosci; 2021 Dec; 71(12):2474-2481. PubMed ID: 34227036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration.
    Duarte K; Heide S; Poëa-Guyon S; Rousseau V; Depienne C; Rastetter A; Nava C; Attié-Bitach T; Razavi F; Martinovic J; Moutard ML; Cherfils J; Mignot C; Héron D; Barnier JV
    Neurobiol Dis; 2020 Mar; 136():104709. PubMed ID: 31843706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of synaptic network dynamics by the intellectual disability protein PAK3.
    Dubos A; Combeau G; Bernardinelli Y; Barnier JV; Hartley O; Gaertner H; Boda B; Muller D
    J Neurosci; 2012 Jan; 32(2):519-27. PubMed ID: 22238087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Self-Injury With Dopamine and Serotonin Replacement Therapy in a Patient With a Hemizygous PAK3 Mutation: A New Therapeutic Strategy for Neuropsychiatric Features of an Intellectual Disability Syndrome.
    Horvath GA; Tarailo-Graovac M; Bartel T; Race S; Van Allen MI; Blydt-Hansen I; Ross CJ; Wasserman WW; Connolly MB; van Karnebeek CDM
    J Child Neurol; 2018 Jan; 33(1):106-113. PubMed ID: 29246092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intellectual disability PAK3 R67C mutation impacts cognitive functions and adult hippocampal neurogenesis.
    Castillon C; Gonzalez L; Domenichini F; Guyon S; Da Silva K; Durand C; Lestaevel P; Vaillend C; Laroche S; Barnier JV; Poirier R
    Hum Mol Genet; 2020 Jul; 29(12):1950-1968. PubMed ID: 31943058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation.
    Bienvenu T; des Portes V; McDonell N; Carrié A; Zemni R; Couvert P; Ropers HH; Moraine C; van Bokhoven H; Fryns JP; Allen K; Walsh CA; Boué J; Kahn A; Chelly J; Beldjord C
    Am J Med Genet; 2000 Aug; 93(4):294-8. PubMed ID: 10946356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p21-activated kinase PAK3 forms heterodimers with PAK1 in brain implementing trans-regulation of PAK3 activity.
    Combeau G; Kreis P; Domenichini F; Amar M; Fossier P; Rousseau V; Barnier JV
    J Biol Chem; 2012 Aug; 287(36):30084-96. PubMed ID: 22815483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing in children of women with skewed X-inactivation identifies atypical cases and complex phenotypes.
    Giorgio E; Brussino A; Biamino E; Belligni EF; Bruselles A; Ciolfi A; Caputo V; Pizzi S; Calcia A; Di Gregorio E; Cavalieri S; Mancini C; Pozzi E; Ferrero M; Riberi E; Borelli I; Amoroso A; Ferrero GB; Tartaglia M; Brusco A
    Eur J Paediatr Neurol; 2017 May; 21(3):475-484. PubMed ID: 28027854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAK3 related mental disability: further characterization of the phenotype.
    Peippo M; Koivisto AM; Särkämö T; Sipponen M; von Koskull H; Ylisaukko-oja T; Rehnström K; Froyen G; Ignatius J; Järvelä I
    Am J Med Genet A; 2007 Oct; 143A(20):2406-16. PubMed ID: 17853471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-Activated Kinase 3 (PAK3)-Related Intellectual Disability Associated with Combined Immunodeficiency: A Case Report.
    Almutairi O; Almutairi HA; Al Rushood M
    Am J Case Rep; 2021 May; 22():e930966. PubMed ID: 34014906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDM5C mutational screening among males with intellectual disability suggestive of X-Linked inheritance and review of the literature.
    Gonçalves TF; Gonçalves AP; Fintelman Rodrigues N; dos Santos JM; Pimentel MM; Santos-Rebouças CB
    Eur J Med Genet; 2014 Mar; 57(4):138-44. PubMed ID: 24583395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in two large pedigrees highlight the role of ZNF711 in X-linked intellectual disability.
    van der Werf IM; Van Dijck A; Reyniers E; Helsmoortel C; Kumar AA; Kalscheuer VM; de Brouwer AP; Kleefstra T; van Bokhoven H; Mortier G; Janssens S; Vandeweyer G; Kooy RF
    Gene; 2017 Mar; 605():92-98. PubMed ID: 27993705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal recessive mutations in THOC6 cause intellectual disability: syndrome delineation requiring forward and reverse phenotyping.
    Amos JS; Huang L; Thevenon J; Kariminedjad A; Beaulieu CL; Masurel-Paulet A; Najmabadi H; Fattahi Z; Beheshtian M; Tonekaboni SH; Tang S; Helbig KL; Alcaraz W; Rivière JB; Faivre L; Innes AM; Lebel RR; Boycott KM;
    Clin Genet; 2017 Jan; 91(1):92-99. PubMed ID: 27102954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond Ohdo syndrome: A familial missense mutation broadens the MED12 spectrum.
    Langley KG; Brown J; Gerber RJ; Fox J; Friez MJ; Lyons M; Schrier Vergano SA
    Am J Med Genet A; 2015 Dec; 167A(12):3180-5. PubMed ID: 26338144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the Phenotype Associated with NAA10-Related N-Terminal Acetylation Deficiency.
    Saunier C; Støve SI; Popp B; Gérard B; Blenski M; AhMew N; de Bie C; Goldenberg P; Isidor B; Keren B; Leheup B; Lampert L; Mignot C; Tezcan K; Mancini GM; Nava C; Wasserstein M; Bruel AL; Thevenon J; Masurel A; Duffourd Y; Kuentz P; Huet F; Rivière JB; van Slegtenhorst M; Faivre L; Piton A; Reis A; Arnesen T; Thauvin-Robinet C; Zweier C
    Hum Mutat; 2016 Aug; 37(8):755-64. PubMed ID: 27094817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.